Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Clinical Chemistry|August 14, 2013
Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patientsValerie Taly, Deniz Pekin, Leonor Benhaim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2009
Analysis of PTEN, BRAF, and EGFR status in determining benefit from cetuximab therapy in wild-type KRAS metastatic colon cancerPierre Laurent-Puig, Anne Cayre, Gilles Manceau, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 30, 2015
Prognostic value of health-related quality of life in patients with metastatic pancreatic adenocarcinoma: a random forest methodologyMomar Diouf, Thomas Filleron, Anne-Laure Pointet, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
Fixed-dose rate gemcitabine alone or alternating with FOLFIRI.3 (irinotecan, leucovorin and fluorouracil) in the first-line treatment of patients with metastatic pancreatic adenocarcinoma: an AGEO randomised phase II study (FIRGEM)Isabelle Trouilloud, Anne-Claire Dupont-Gossard, David Malka, et al.
Clinics and Research in Hepatology and Gastroenterology|April 30, 2021
Chemotherapy use in end-of-life digestive cancer patients: a retrospective AGEO observational studyAlexandra Lapeyre-Prost, Geraldine Perkins, Marie Vallee, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 31, 2011
Management of gastrointestinal stromal tumours of limited size: proposals from a French panel of physiciansBruno Landi, Olivier Bouché, Rosine Guimbaud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2008
KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximabAstrid Lièvre, Jean-Baptiste Bachet, Valérie Boige, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 22, 2012
Outcome of patients with platelet-derived growth factor receptor alpha-mutated gastrointestinal stromal tumors in the tyrosine kinase inhibitor eraPhilippe A Cassier, Elena Fumagalli, Piotr Rutkowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2014
Clinical relevance of KRAS-mutated subclones detected with picodroplet digital PCR in advanced colorectal cancer treated with anti-EGFR therapyPierre Laurent-Puig, Deniz Pekin, Corinne Normand, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 2021
Circulating tumor DNA is a prognostic marker of tumor recurrence in stage II and III colorectal cancer: multicentric, prospective cohort study (ALGECOLS)Leonor Benhaim, Olivier Bouché, Corinne Normand, et al.
Pageof 6